- Home
- OPK vs DX Comparison
OPK vs DX Comparison
Compare OPK & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- DX
- Stock Information
- Founded
- OPK 2007
- DX 1987
- Country
- OPK United States
- DX United States
- Employees
- OPK N/A
- DX N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- DX Real Estate Investment Trusts
- Sector
- OPK Health Care
- DX Real Estate
- Exchange
- OPK Nasdaq
- DX Nasdaq
- Market Cap
- OPK 1.1B
- DX 984.9M
- IPO Year
- OPK 1995
- DX N/A
- Fundamental
- Price
- OPK $1.56
- DX $12.49
- Analyst Decision
- OPK Strong Buy
- DX Strong Buy
- Analyst Count
- OPK 3
- DX 5
- Target Price
- OPK $2.75
- DX $13.33
- AVG Volume (30 Days)
- OPK 4.8M
- DX 2.3M
- Earning Date
- OPK 11-07-2024
- DX 10-21-2024
- Dividend Yield
- OPK N/A
- DX 14.44%
- EPS Growth
- OPK N/A
- DX 1170.16
- EPS
- OPK N/A
- DX 1.22
- Revenue
- OPK $711,408,000.00
- DX $123,176,000.00
- Revenue This Year
- OPK N/A
- DX N/A
- Revenue Next Year
- OPK $0.50
- DX $2,200.43
- P/E Ratio
- OPK N/A
- DX $10.21
- Revenue Growth
- OPK N/A
- DX 172.15
- 52 Week Low
- OPK $0.85
- DX $11.12
- 52 Week High
- OPK $1.75
- DX $13.13
- Technical
- Relative Strength Index (RSI)
- OPK 52.14
- DX 52.78
- Support Level
- OPK $1.55
- DX $12.31
- Resistance Level
- OPK $1.68
- DX $12.55
- Average True Range (ATR)
- OPK 0.08
- DX 0.22
- MACD
- OPK 0.01
- DX 0.01
- Stochastic Oscillator
- OPK 55.88
- DX 69.41
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including residential MBS and commercial MBS.